Michael S. Brown
At a glance: Michael S. Brown is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 3, 2026, reported a sale of $1.7M. On file: 0 purchase lines ($0) and 1 sale line ($1.7M).
Disclosed holdings: about $1.3M of REGN stock: 1,380 shares reported on their latest Form 4 (filed Nov 3, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1,9291,380 held (−58%) | $875.00 | $1.7M | +6.6% |
- Sell
Director Michael S Brown sold $1.7M of REGN at $875.00 — cuts the stake by 58%; pre-scheduled 10b5-1 plan sale.
Follow Michael S. Brown
Get one email when Michael S. Brown files a new purchase or sale. Free.
At most one email a day about Michael S. Brown, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.